BackNymox Pharmaceutical Overview

Nymox Pharmaceutical Net Income

Profitability analysis for NYMX.

Quarterly Net Income

-$1.11M
124.92% YoY

As of Jun 2023

Annual Net Income (TTM)

-$8.49M
25.92% YoY

Trailing 12 months ending Jun 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...